Skip to content
MedsAcross

Manufacturer

Supernus Pharmaceuticals

Pharmaceutical manufacturer based in United States
United States
Products listed
12
Molecules
4
Therapy areas
2

Supernus Pharmaceuticals is a pharmaceutical manufacturer based in United States. MedsAcross lists 12 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
United States
Indian manufacturer
No
Also listed as
Supernus Pharmaceuticals, Inc, Supernus Pharmaceuticals, Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Supernus Pharmaceuticals products through licensed channels, with the documents your regulator needs.

Neurology

9 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Gocovri 137 mg capsuleOralAmantadineUS FDAAvailable on request
Gocovri 68.5 mg capsuleOralAmantadineUS FDAAvailable on request
Oxtellar XR 150 mg tabletOralOxcarbazepineUS FDAAvailable on request
Oxtellar XR 300 mg tabletOralOxcarbazepineUS FDAAvailable on request
Oxtellar XR 600 mg tabletOralOxcarbazepineUS FDAAvailable on request
Trokendi XR 100 mg extended-release capsuleOralTopiramateUS FDAAvailable on request
Trokendi XR 200 mg extended-release capsuleOralTopiramateUS FDAAvailable on request
Trokendi XR 25 mg extended-release capsuleOralTopiramateUS FDAAvailable on request
Trokendi XR 50 mg extended-release capsuleOralTopiramateUS FDAAvailable on request

Psychiatry

3 presentations

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Qelbree 100 mg extended-release capsuleOralViloxazineUS FDAAvailable on request
Qelbree 150 mg extended-release capsuleOralViloxazineUS FDAAvailable on request
Qelbree 200 mg extended-release capsuleOralViloxazineUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Supernus Pharmaceuticals

Send a request for any of these products. We confirm the licensed source, documents and lead time.